Deere (DE) earned an adjusted $2.14 per share for its latest quarter, easily beating estimates of $1.68. Revenue was slightly below forecasts, but Deere raised its revenue and sales forecast for the year based on improving market conditions.
Campbell Soup (CPB) reported adjusted quarterly profit of 59 cents per share, 5 cents short of estimate, while revenue fell short as well with Campbell citing difficult industry conditions. Campbell also cut its sales outlook for the year but did raise the lower end of its earnings forecast.
Foot Locker (FL) fell 2 cents short of estimates with quarterly profit of $1.36 per share. Revenue also fell short of Street projections, and a same-store sales increases of 0.5 percent was below forecasts of a 1.5 percent increase.
In what's been a tough earnings season for retailers, Gap (GPS) beat expectations on quarterly profit and revenue. The company behind the Gap, Old Navy, and Banana Republic brands also boosted forward guidance.
Ross Stores (ROST) beat estimates by 2 cents with quarterly profit of 82 cents per share, while the discount retailer's revenue also beat forecasts. Ross also reported upbeat comparable store sales, and raised its full-year forecast.
Salesforce.com (CRM) reported adjusted quarterly profit of 28 cents per share, 2 cents above estimates, while revenue was slightly above forecasts as well. Salesforce also raised its full year revenue guidance due to strong demand for its cloud-based business software.
Autodesk (ADSK) lost 16 cents per share for its latest quarter, but that loss was smaller than the 24 cents expected by analysts. The design software maker also saw revenue beat estimates, with the company seeing strong increases in subscription numbers.
Applied Materials (AMAT) came in 3 cents above estimates with adjusted quarterly earnings of 79 cents per share, and its revenue was slightly above forecasts. The maker of semiconductor manufacturing equipment has posted record profits for four consecutive quarters.
McKesson (MCK) reported adjusted quarterly profit of $3.39 per share, compared to estimates of $3 per share, although the drug distributor saw revenue come in below forecasts. McKesson's results were boosted by results in pharmaceutical distribution and services.
Johnson & Johnson (JNJ) unit Janssen is suing to block a copy of its rheumatoid arthritis drug Remicade from being sold in the US. The copy is made by South Korea's Samsung Bioepis Co.
Mallinckrodt (MNK) and Express Scripts (ESRX) came under fire from short seller Jim Chanos at SkyBridge Capital's SALT Conference in Las Vegas, with Chanos slamming the alliance between the two for helping keep drug prices high.